Stay updated on Pembrolizumab Plus Lenvatinib Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab Plus Lenvatinib Clinical Trial page.

Latest updates to the Pembrolizumab Plus Lenvatinib Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedThe page’s interface revision/version label was updated to a newer revision (v3.5.3) without changing the underlying study details shown on the record.SummaryDifference0.0%

- Check21 days agoChange DetectedAdded Temuco, Araucania, Chile, 4780000 as a new site and removed Temuco, Región de la Araucanía, Chile, 4780000, updating the region name from Región de la Araucanía to Araucania. Revision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check28 days agoNo Change Detected
- Check43 days agoChange DetectedNaples, Italy (80131) was added as a study site and Napoli, Italy (80131) was removed; Abbotsford listing formatting was updated to Abbotsford British Columbia, British Columbia, Canada, V2S 0C2.SummaryDifference0.1%

- Check50 days agoChange Detected- Revision updated to v3.5.0; previous revision v3.4.3 was removed.SummaryDifference0.0%

- Check64 days agoChange DetectedAdded a publication entry for LEAP-005 colorectal cancer results with the full author list; updated the revision from v3.4.2 to v3.4.3.SummaryDifference0.1%

- Check87 days agoChange DetectedGastric cancer was added to the list of conditions, and the page revision was updated to v3.4.2.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab Plus Lenvatinib Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Plus Lenvatinib Clinical Trial page.